Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure. (March 2016)
- Record Type:
- Journal Article
- Title:
- Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure. (March 2016)
- Main Title:
- Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure
- Authors:
- Monneret, D.
Tamisier, R.
Ducros, V.
Faure, P.
Halimi, S.
Baguet, J.P.
Lévy, P.
Pépin, J.L.
Borel, A.L. - Abstract:
- Abstract: Background: Insulin resistance, glucose dyshomeostasis and oxidative stress are associated to the cardiovascular consequences of obstructive sleep apnea (OSA). The effects of a long-term continuous positive airway pressure (LT-CPAP) treatment on such mechanisms still remain conflicting. Objective: To investigate the effect of LT-CPAP on glucose tolerance, insulin sensitivity, oxidative stress and cardiovascular biomarkers in non-obese non-diabetic OSA patients. Patients & methods: Twenty-eight apneic, otherwise healthy, men suffering from OSA (mean age = 48.9 ± 9.4 years; apnea-hypopnea index = 41.1 ± 16.1 events/h; BMI = 26.6 ± 2.8 kg/m 2 ; fasting glucose = 4.98 ± 0.37 mmol/L) were evaluated before and after LT-CPAP by an oral glucose tolerance test (OGTT), measuring plasma glucose, insulin and proinsulin. Glycated hemoglobin, homeostasis model assessment resistance insulin, blood lipids, oxidative stress, homocysteine and NT-pro-brain natriuretic peptide (NT-proBNP) were also measured. Results: LT-CPAP treatment lasted 13.9 ± 6.5 months. At baseline, the time spent at SaO2 <90%, minimal and mean SaO2 were associated with insulin area under the curve during OGTT (r = 0.448, P = 0.011; r = −0.382; P = 0.047 and r = −0.424; P = 0.028, respectively) and most other glucose/insulin homeostasis biomarkers, as well as with homocysteine (r = 0.531, P = 0.006; r = −0.487; P = 0.011 and r = −0.409; P = 0.034, respectively). LT-CPAP had no effect on all theAbstract: Background: Insulin resistance, glucose dyshomeostasis and oxidative stress are associated to the cardiovascular consequences of obstructive sleep apnea (OSA). The effects of a long-term continuous positive airway pressure (LT-CPAP) treatment on such mechanisms still remain conflicting. Objective: To investigate the effect of LT-CPAP on glucose tolerance, insulin sensitivity, oxidative stress and cardiovascular biomarkers in non-obese non-diabetic OSA patients. Patients & methods: Twenty-eight apneic, otherwise healthy, men suffering from OSA (mean age = 48.9 ± 9.4 years; apnea-hypopnea index = 41.1 ± 16.1 events/h; BMI = 26.6 ± 2.8 kg/m 2 ; fasting glucose = 4.98 ± 0.37 mmol/L) were evaluated before and after LT-CPAP by an oral glucose tolerance test (OGTT), measuring plasma glucose, insulin and proinsulin. Glycated hemoglobin, homeostasis model assessment resistance insulin, blood lipids, oxidative stress, homocysteine and NT-pro-brain natriuretic peptide (NT-proBNP) were also measured. Results: LT-CPAP treatment lasted 13.9 ± 6.5 months. At baseline, the time spent at SaO2 <90%, minimal and mean SaO2 were associated with insulin area under the curve during OGTT (r = 0.448, P = 0.011; r = −0.382; P = 0.047 and r = −0.424; P = 0.028, respectively) and most other glucose/insulin homeostasis biomarkers, as well as with homocysteine (r = 0.531, P = 0.006; r = −0.487; P = 0.011 and r = −0.409; P = 0.034, respectively). LT-CPAP had no effect on all the OGTT-related measurements, but increased plasma total antioxidant status (+7.74%; P = 0.035) in a duration-dependent manner (r = 0.607; P < 0.001), and decreased both homocysteine (−15.2%; P = 0.002) and NT-proBNP levels (−39.3%; P = 0.002). Conclusions: In non-obese non-diabetic OSA patients, nocturnal oxygen desaturation is strongly associated to insulin resistance. LT-CPAP does not improve glucose homeostasis nor insulin sensitivity but has a favorable effect on antioxidant capacity and cardiovascular risk biomarkers. Highlights: Insulin resistance and raised oxidative stress are linked to obstructive sleep apnea. These metabolic disorders lead to the deleterious cardiovascular consequences of OSA. The effects of long-term CPAP in non-obese non-diabetic OSA patients are studied. Long-term CPAP does not improve glucose homeostasis nor insulin sensitivity. But it has a favorable effect on antioxidant capacity and cardiovascular biomarkers. … (more)
- Is Part Of:
- Respiratory medicine. Volume 112(2016)
- Journal:
- Respiratory medicine
- Issue:
- Volume 112(2016)
- Issue Display:
- Volume 112, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 112
- Issue:
- 2016
- Issue Sort Value:
- 2016-0112-2016-0000
- Page Start:
- 119
- Page End:
- 125
- Publication Date:
- 2016-03
- Subjects:
- Obstructive sleep apnea -- Glucose tolerance -- Oxidative stress -- Long-term CPAP -- Cardiovascular risk -- Biomarkers
AHI apnea-hypopnea index -- AUC area under curve -- BMI body mass index -- CPAP continuous positive airway pressure -- CIMT carotid intima-media thickness -- DBP diastolic blood pressure -- GPX glutathione peroxidase -- HbA1c glycated hemoglobin A1c -- HOMA-RI homeostasis model assessment resistance insulin -- hsCRP high-sensitive C-reactive protein -- LC/MS/MS liquid chromatography-tandem mass spectrometry -- NT-proBNP N-terminal pro-brain natriuretic peptide -- OGTT oral glucose tolerance test -- OSA obstructive sleep apnea -- PTAS plasma total antioxidant status -- RDI respiratory disturbance index -- SaO2 arterial oxygen saturation -- SaO2<90%TST sleep time spent at SaO2<90% -- SBP systolic blood pressure -- TST total sleep time
Chest -- Diseases -- Periodicals
Chest -- Diseases -- Great Britain -- Periodicals
Respiratory organs -- Diseases -- Periodicals
Respiratory Tract Diseases -- Periodicals
Appareil respiratoire -- Maladies -- Périodiques
Thorax -- Maladies -- Périodiques
Appareil respiratoire -- Maladies -- Traitement -- Périodiques
Electronic journals
616.2 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09546111 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09546111 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09546111 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.rmed.2016.01.015 ↗
- Languages:
- English
- ISSNs:
- 0954-6111
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7777.661900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2265.xml